| Code | CSB-RA008540MA1HU |
| Size | US$210 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
FCGR2A, commonly known as CD32a, serves as a critical low-affinity receptor for the Fc region of immunoglobulin G and plays a central role in immune complex processing, phagocytosis, and inflammatory responses. Expressed predominantly on myeloid cells including monocytes, macrophages, and neutrophils, this receptor bridges humoral and cellular immunity by translating antibody recognition into effector cell activation. Understanding FCGR2A biology has significant implications for research into autoimmune diseases, vaccine responses, and therapeutic antibody mechanisms.
This recombinant monoclonal antibody, clone 5H2, offers the consistency and reliability that demanding immunological research requires. Produced using recombinant technology with a defined human IgG1 framework, this antibody eliminates the lot-to-lot variability inherent in traditional hybridoma production. Researchers can confidently build upon previous results knowing that antibody performance remains constant across experiments and extended study timelines.
Functional validation demonstrates robust binding activity against human FCGR2A. In ELISA-based binding assays using immobilized recombinant human FCGR2A protein, this antibody exhibits strong target engagement with an EC50 range of 24.44–32.57 ng/mL, confirming high-affinity recognition suitable for sensitive detection applications. The recommended working dilution range of 1:5000 to 1:50000 for ELISA provides flexibility to optimize signal-to-background ratios across different experimental conditions.
Supplied in a stabilized liquid format containing glycerol and PBS with Proclin 300 preservative, this antibody is ready for immediate use and maintains stability when stored at -20°C or -80°C. For investigators studying Fc receptor biology, immune cell activation, or therapeutic antibody mechanisms, this recombinant anti-FCGR2A antibody delivers the reproducible performance essential for advancing immunology research.
There are currently no reviews for this product.